페서리 시장 규모, 점유율, 동향 분석 보고서 : 유형별, 최종 용도별, 지역별, 부문별 예측(2025-2030년)

Pessary Market Growth & Trends:

The global pessary market size is expected to reach USD 590.5 million by 2030, registering a CAGR of 4.6% from 2025 to 2030, according to a new report by Grand View Research, Inc. An increase in the demand for pessaries has been witnessed in recent years as compared to the surgeries performed for pelvic organ prolapse. Easy and convenient application has largely favored the growing usage of pessaries among patients.

According to the U.S. Census Bureau, the number of women aged 65 years and above in America would double by 2030 to reach over 40 million. Vaginal pessaries have a high success rate and minimal complication rate for the treatment of both incontinence and prolapse. When successfully fitted, they are associated with high patient satisfaction.

Sedentary lifestyles and lifestyle-associated diseases are also expected to contribute to market growth. The increasing prevalence of diseases such as urinary inconsistency, pelvic organ prolapse and the rising number of geriatric population is fueling the demand for vaginal pessaries.

The market for vaginal pessary is competitive. The most notable participants in the market are CooperSurgical, Biotique America, and MedGyn. Key players are involved in new product launches, acquisitions, and partnerships to gain a competitive edge over each other. For instance, CooperSurgical, based in the United States, invented the Milex Pessary Fitting Kit. The kit is designed for physicians and doctors who can use it to determine the exact size of the patient and prescribe the pessary accordingly. The introduction of these detailed analyses marks a significant shift in focus in the field of female healthcare around the world, which is propelling the market forward.

Pessary Market Report Highlights:

• In terms of type, the ring pessary segment dominated the market in 2024, since the device is easy to insert and remove
• The hospitals segment held the largest revenue share in 2024, as they are the primary point of care for treatment, furthermore, hospitals are known to offer superior care to their patients, and treatment at these centers are generally reimbursed, which drives adoption
• The clinic segment is predicted to witness the fastest growth rate over the forecast timeframe due to the increasing number of patient visits and advanced infrastructure in clinics
• North America dominated the market in 2024 due to the increasing R&D spending, rising demand for medication development, strong governmental efforts, and current projects
• Asia Pacific is expected to register the fastest growth rate owing to numerous untapped growth opportunities in diagnostics and ever-increasing prevalence of pelvic organ prolapse

Table of Contents

Chapter 1. Methodology and Scope

• 1.1. Market Segmentation and Scope
• 1.1. Segment Definitions
  • 1.1.1. Type
  • 1.1.2. End-Use
  • 1.1.3. Regional scope
  • 1.1.4. Estimates and forecasts timeline
• 1.2. Research Methodology
• 1.3. Information Procurement
  • 1.3.1. Purchased database
  • 1.3.2. GVR's internal database
  • 1.3.3. Secondary sources
  • 1.3.4. Primary research
  • 1.3.5. Details of primary research
    • 1.3.5.1. Data for primary interviews in North America
    • 1.3.5.2. Data for primary interviews in Europe
    • 1.3.5.3. Data for primary interviews in Asia Pacific
    • 1.3.5.4. Data for primary interviews in Latin America
    • 1.3.5.5. Data for Primary interviews in MEA
• 1.4. Information or Data Analysis
  • 1.4.1. Data analysis models
• 1.5. Market Formulation & Validation
• 1.6. Model Details
  • 1.6.1. Commodity flow analysis (Model 1)
  • 1.6.2. Approach 1: Commodity flow approach
  • 1.6.3. Volume price analysis (Model 2)
  • 1.6.4. Approach 2: Volume price analysis
• 1.7. List of Secondary Sources
• 1.8. List of Primary Sources
• 1.9. Objectives

Chapter 2. Executive Summary

• 2.1. Market Outlook
• 2.2. Segment Outlook
  • 2.2.1. Type outlook
  • 2.2.2. End Use outlook
• 2.3. Regional outlook
• 2.4. Competitive Insights

Chapter 3. Pessary Market Variables, Trends & Scope

• 3.1. Market Lineage Outlook
  • 3.1.1. Parent Market Outlook
  • 3.1.2. Related/ancillary market outlook
• 3.2. Market Dynamics
  • 3.2.1. Market Driver Analysis
    • 3.2.1.1. Rising prevalence of pelvic organ prolapse (POP) and urinary incontinence
    • 3.2.1.2. Increasing awareness about women's health
    • 3.2.1.3. Technological advancements in pessary design
  • 3.2.2. Market Restraint Analysis
    • 3.2.2.1. Limited awareness about pessary usage
    • 3.2.2.2. Discomfort or complications such as infections with prolonged use
• 3.3. Pessary Market Analysis Tools
  • 3.3.1. Industry Analysis - Porter's
    • 3.3.1.1. Bargaining power of suppliers
    • 3.3.1.2. Bargaining power of buyers
    • 3.3.1.3. Threat of substitutes
    • 3.3.1.4. Threat of new entrants
    • 3.3.1.5. Competitive rivalry
  • 3.3.2. PESTEL Analysis
    • 3.3.2.1. Political landscape
    • 3.3.2.2. Economic landscape
    • 3.3.2.3. Social landscape
    • 3.3.2.4. Technological landscape
    • 3.3.2.5. Environmental landscape
    • 3.3.2.6. Legal landscape

Chapter 4. Pessary Market: Type Estimates & Trend Analysis

• 4.1. Segment Dashboard
• 4.2. Pessary Market: Type Movement Analysis
• 4.3. Pessary Market by Type Outlook (USD Million)
• 4.4. Market Size & Forecasts and Trend Analyses, 2018 to 2030 for the following
• 4.5. Gellhorn
  • 4.5.1. Gellhorn Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
• 4.6. Ring
  • 4.6.1. Ring Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
• 4.7. Donut
  • 4.7.1. Donut Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
• 4.8. Others
  • 4.8.1. Others Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)

Chapter 5. Pessary Market: End Use Estimates & Trend Analysis

• 5.1. Segment Dashboard
• 5.2. Pessary Market: End Use Movement Analysis
• 5.3. Pessary Market by End Use Outlook (USD Million)
• 5.4. Market Size & Forecasts and Trend Analyses, 2018 to 2030 for the following
• 5.5. Hospitals
  • 5.5.1. Hospitals Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
• 5.6. Clinics
  • 5.6.1. Clinics Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
• 5.7. Ambulatory Surgery Centers
  • 5.7.1. Ambulatory Surgery Centers Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)

Chapter 6. Pessary Market: Regional Estimates & Trend Analysis

• 6.1. Regional Dashboard
• 6.2. Regional Pessary Market Movement Analysis
• 6.3. Pessary Market: Regional Estimates & Trend Analysis 2018 to 2030 for the following
• 6.4. Market Size & Forecasts and Trend Analyses, 2018 to 2030 for the following
• 6.5. North America
  • 6.5.1. North America Pessary Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 6.5.2. U.S.
    • 6.5.2.1. Key Country Dynamics
    • 6.5.2.2. Competitive Scenario
    • 6.5.2.3. Regulatory Framework
    • 6.5.2.4. Reimbursement scenario
    • 6.5.2.5. U.S. Pessary Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 6.5.3. Canada
    • 6.5.3.1. Key Country Dynamics
    • 6.5.3.2. Competitive Scenario
    • 6.5.3.3. Regulatory Framework
    • 6.5.3.4. Reimbursement scenario
    • 6.5.3.5. Canada Pessary Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 6.5.4. Mexico
    • 6.5.4.1. Key Country Dynamics
    • 6.5.4.2. Competitive Scenario
    • 6.5.4.3. Regulatory Framework
    • 6.5.4.4. Reimbursement scenario
    • 6.5.4.5. Mexico Pessary Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 6.5.5. Europe
  • 6.5.6. Europe Pessary Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 6.5.7. UK
    • 6.5.7.1. Key Country Dynamics
    • 6.5.7.2. Competitive Scenario
    • 6.5.7.3. Regulatory Framework
    • 6.5.7.4. Reimbursement scenario
    • 6.5.7.5. UK Pessary Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 6.5.8. Germany
    • 6.5.8.1. Key Country Dynamics
    • 6.5.8.2. Competitive Scenario
    • 6.5.8.3. Regulatory Framework
    • 6.5.8.4. Reimbursement scenario
    • 6.5.8.5. Germany Pessary Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 6.5.9. France
    • 6.5.9.1. Key Country Dynamics
    • 6.5.9.2. Competitive Scenario
    • 6.5.9.3. Regulatory Framework
    • 6.5.9.4. Reimbursement scenario
    • 6.5.9.5. France Pessary Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 6.5.10. Italy
    • 6.5.10.1. Key Country Dynamics
    • 6.5.10.2. Competitive Scenario
    • 6.5.10.3. Regulatory Framework
    • 6.5.10.4. Reimbursement scenario
    • 6.5.10.5. Italy Pessary Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 6.5.11. Spain
    • 6.5.11.1. Key Country Dynamics
    • 6.5.11.2. Competitive Scenario
    • 6.5.11.3. Regulatory Framework
    • 6.5.11.4. Reimbursement scenario
    • 6.5.11.5. Spain Pessary Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 6.5.12. Denmark
    • 6.5.12.1. Key Country Dynamics
    • 6.5.12.2. Competitive Scenario
    • 6.5.12.3. Regulatory Framework
    • 6.5.12.4. Reimbursement scenario
    • 6.5.12.5. Denmark Pessary Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 6.5.13. Sweden
    • 6.5.13.1. Key Country Dynamics
    • 6.5.13.2. Competitive Scenario
    • 6.5.13.3. Regulatory Framework
    • 6.5.13.4. Reimbursement scenario
    • 6.5.13.5. Sweden Pessary Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 6.5.14. Norway
    • 6.5.14.1. Key Country Dynamics
    • 6.5.14.2. Competitive Scenario
    • 6.5.14.3. Regulatory Framework
    • 6.5.14.4. Reimbursement scenario
    • 6.5.14.5. Norway Pessary Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 6.5.15. Asia Pacific
  • 6.5.16. Asia Pacific Pessary Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 6.5.17. Japan
    • 6.5.17.1. Key Country Dynamics
    • 6.5.17.2. Competitive Scenario
    • 6.5.17.3. Regulatory Framework
    • 6.5.17.4. Reimbursement scenario
    • 6.5.17.5. Japan Pessary Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 6.5.18. China
    • 6.5.18.1. Key Country Dynamics
    • 6.5.18.2. Competitive Scenario
    • 6.5.18.3. Regulatory Framework
    • 6.5.18.4. Reimbursement scenario
    • 6.5.18.5. China Pessary Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 6.5.19. India
    • 6.5.19.1. Key Country Dynamics
    • 6.5.19.2. Competitive Scenario
    • 6.5.19.3. Regulatory Framework
    • 6.5.19.4. Reimbursement scenario
    • 6.5.19.5. India Pessary Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 6.5.20. South Korea
    • 6.5.20.1. Key Country Dynamics
    • 6.5.20.2. Competitive Scenario
    • 6.5.20.3. Regulatory Framework
    • 6.5.20.4. Reimbursement scenario
    • 6.5.20.5. South Korea Pessary Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 6.5.21. Australia
    • 6.5.21.1. Key Country Dynamics
    • 6.5.21.2. Competitive Scenario
    • 6.5.21.3. Regulatory Framework
    • 6.5.21.4. Reimbursement scenario
    • 6.5.21.5. Australia Pessary Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 6.5.22. Thailand
    • 6.5.22.1. Key Country Dynamics
    • 6.5.22.2. Competitive Scenario
    • 6.5.22.3. Regulatory Framework
    • 6.5.22.4. Reimbursement scenario
    • 6.5.22.5. Thailand Pessary Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 6.5.23. Latin America
  • 6.5.24. Latin America Pessary Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 6.5.25. Brazil
    • 6.5.25.1. Key Country Dynamics
    • 6.5.25.2. Competitive Scenario
    • 6.5.25.3. Regulatory Framework
    • 6.5.25.4. Reimbursement scenario
    • 6.5.25.5. Brazil Pessary Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 6.5.26. Argentina
    • 6.5.26.1. Key Country Dynamics
    • 6.5.26.2. Competitive Scenario
    • 6.5.26.3. Regulatory Framework
    • 6.5.26.4. Reimbursement scenario
    • 6.5.26.5. Argentina Pessary Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 6.5.27. Middle East & Africa
  • 6.5.28. Middle East & Africa Pessary Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 6.5.29. South Africa
    • 6.5.29.1. Key Country Dynamics
    • 6.5.29.2. Competitive Scenario
    • 6.5.29.3. Regulatory Framework
    • 6.5.29.4. Reimbursement scenario
    • 6.5.29.5. South Africa Pessary Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 6.5.30. Saudi Arabia
    • 6.5.30.1. Key Country Dynamics
    • 6.5.30.2. Competitive Scenario
    • 6.5.30.3. Regulatory Framework
    • 6.5.30.4. Reimbursement scenario
    • 6.5.30.5. Saudi Arabia Pessary Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 6.5.31. UAE
    • 6.5.31.1. Key Country Dynamics
    • 6.5.31.2. Competitive Scenario
    • 6.5.31.3. Regulatory Framework
    • 6.5.31.4. Reimbursement scenario
    • 6.5.31.5. UAE Pessary Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 6.5.32. Kuwait
    • 6.5.32.1. Key Country Dynamics
    • 6.5.32.2. Competitive Scenario
    • 6.5.32.3. Regulatory Framework
    • 6.5.32.4. Reimbursement scenario
    • 6.5.32.5. Kuwait Pessary Market Estimates and Forecasts, 2018 - 2030 (USD Million)

Chapter 7. Competitive Landscape

• 7.1. Market Participant Categorization
• 7.2. Key Company Profiles
  • 7.2.1. CooperSurgical Inc.
    • 7.2.1.1. Company overview
    • 7.2.1.2. Financial performance
    • 7.2.1.3. Product benchmarking
    • 7.2.1.4. Strategic initiatives
  • 7.2.2. Bliss GVS Pharma Limited
    • 7.2.2.1. Company overview
    • 7.2.2.2. Financial performance
    • 7.2.2.3. Product benchmarking
    • 7.2.2.4. Strategic initiatives
  • 7.2.3. MedGyn Products, Inc.
    • 7.2.3.1. Company overview
    • 7.2.3.2. Financial performance
    • 7.2.3.3. Product benchmarking
    • 7.2.3.4. Strategic initiatives
  • 7.2.4. Panpac Medical Corp.
    • 7.2.4.1. Company overview
    • 7.2.4.2. Financial performance
    • 7.2.4.3. Product benchmarking
    • 7.2.4.4. Strategic initiatives
  • 7.2.5. Bioteque America Inc.
    • 7.2.5.1. Company overview
    • 7.2.5.2. Financial performance
    • 7.2.5.3. Product benchmarking
    • 7.2.5.4. Strategic initiatives
  • 7.2.6. Personal Medical Corp.
    • 7.2.6.1. Company overview
    • 7.2.6.2. Financial performance
    • 7.2.6.3. Product benchmarking
    • 7.2.6.4. Strategic initiatives
  • 7.2.7. Dr. Arabin GmbH & Co. KG
    • 7.2.7.1. Company overview
    • 7.2.7.2. Financial performance
    • 7.2.7.3. Product benchmarking
    • 7.2.7.4. Strategic initiatives
  • 7.2.8. INTEGRA LIFESCIENCES
    • 7.2.8.1. Company overview
    • 7.2.8.2. Financial performance
    • 7.2.8.3. Product benchmarking
    • 7.2.8.4. Strategic initiatives